De Quervain’s disease (etiology, pathogenesis, diagnosis and treatment). Part II

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access


De Quervain’s disease, despite its low prevalence, is accompanied by pain syndrome, dysfunction and a decrease in the strength of the hand. This leads to a significant decrease in the quality of life of the patient, disruption of his work and daily activities. Patients with de Quervain’s disease, make up a significant part of those who turn to orthopedists, surgeons, rehabilitation doctors. However, the individual features of the structure of the first back canal of each person, formed in the process of phylogenesis, the lack of data on the exact cause of the disease cause the complexity of diagnosis and treatment of the disease. In the first part of the lecture, devoted to de Quervain’s disease, modern literature data concerning the features of the anatomical structure of the first back canal, the etiology and pathogenesis of the disease are summarized. It also presents a description of the clinical picture of de Quervain’s disease, tests and instrumental methods of diagnosis, the algorithm of examination of the patient with this pathology.

Full Text

Restricted Access

About the authors

A. V Novikov

Volga research medical University of the Ministry of health of Russia

Nizhny Novgorod, Russia

M. A Shchedrina

Volga research medical University of the Ministry of health of Russia

Nizhny Novgorod, Russia

S. V Petrov

Volga research medical University of the Ministry of health of Russia

Nizhny Novgorod, Russia


  1. Lane L.B., Boretz R.S., Stuchin S.A. Treatment of de Quervain’s disease:role of conservative management. J. Hand Surg. Br. 2001;26(3):258-60.
  2. Jirarattanaphochai K., Saengnipanthkul S., Vipulakorn K. et al. Treatment of de Quervain disease with triamcinolone injection with or without nimesulide. A randomized, double-blind, placebo-controlled trial. J. Bone Joint Surg. 2004;86A(12):2700-6.
  3. Patel M.R., Bassini L. Trigger fingers and thumb: when to splint, inject, or operate. J. Hand Surg. Am. 1992;17(1):110-3.
  4. Weiss A.P., Akelman E., Tabatabai M. Treatment of de Quervain’s disease. J.Hand Surg. Am. 1994;19(4):595-8.
  5. Richie C.A., Briner W.W. Jr. Corticosteroid injection for treatment of de Quervain’s tenosynovitis: a pooled quantitative literature evaluation. J. Am. Board Fam. Pract. 2003;16(2):102-6.
  6. Rankin M.E., Rankin E. Injection therapy for management of stenosing tenosynovitis (de Quervain’s disease) of the wrist. J. Natl. Med. Assoc. 1998;90(8):474-6.
  7. Rowland P., Phelan N., Gardiner S. et al. The Effectiveness of Corticosteroid Injection for De Quervain’s Stenosing Tenosynovitis (DQST): A Systematic Review and Meta-Analysis. Open Orthop. J. 2015;30(9):437-44.
  8. Sakai N. Selective corticosteroid injection into the extensor pollicis brevis tenosynovium for de Quervain’s disease. Orthopedics. 2002;25(1):68-70.
  9. Apimonbutr P., Budhraja N. Suprafibrous injection with corticosteroid in de Quervain’s disease. J. Med. Assoc. Thai. 2003;86(3):232-7.
  10. Ашкенази А.И. Хирургия кистевого сустава. Текст. М.: Медицина; 1990.
  11. Chambers R.G.Jr. Corticosteroid injections for trigger finger. Am. Fam. Physician. 2009;80(5):454.
  12. Goldfarb C.A., Gelberman R.H., McKeon K. et al. Extra-Articular Steroid Injection: Early Patient Response and the Incidence of Flare Reaction. J. Hand Surg. 2007;32(10):1513-20.
  13. Akram M., Shahzad M.L., Farooqi F.M. et al. Results of injection corticosteroids in treatment of De Quervain’s Tenosynovitis. J. Pak. Med. Assoc. 2014;64(12):30-3.
  14. Wharton R., Thaya M., Eckersley R. The dangers of injecting blind: Abductor pollicis longus tendon rupture in de Quervain’s disease. J. Hand Surg. Eur. Vol. 2015;40(3):322-3.
  15. Venkatesan P., Fangman W.L. Linear hypopigmentation and cutaneous atrophy following intra-articular steroid injections for de Quervain’s tendonitis. J. Drugs Dermatol. 2009;8(5):492-3.
  16. Liang J., McElroy K. Hypopigmentation after triamcinolone injection for de Quervain tenosynovitis. Am. J. Phys. Med. Rehabil. 2013;92(7):639.
  17. Ashraf M.O., Devadoss V.G. Systematic review and meta-analysis on steroid injection therapy for de Quervain’s tenosynovitis in adults. Eur. J. Orthop. Surg. Traumatol. 2014;24(2):149-57.
  18. Peters-Veluthamaningal C., Winters J.C., Groenier K.H., Meyboom-DeJong B. Randomised controlled trial of local corticosteroid injections for de Quervain’s tenosynovitis in general practice. BMC Musculoskelet. Disord. 2009;10:131.
  19. Anderson B.C., Manthey R., Brouns M.C. Treatment of De Quervain’s tenosynovitis with corticosteroids. A prospective study of the response to local injection. Arthritis Rheum. 1991;34(7):793-8.
  20. Oh J.K., Messing S., Hyrien O., Hammert W.C. Effectiveness of Corticosteroid Injections for Treatment of de Quervain’s Tenosynovitis. Hand (N Y). 2017;12(4):357-61.
  21. Earp B.E., Han C.H., Floyd W.E. et al. De Quervain tendinopathy: survivorship and prognostic indicators of recurrence following a single corticosteroid injection. J. Hand Surg. Am. 2015;40(6):1161-5.
  22. Sakai N. Selective corticosteroid injection into the extensor pollicis brevis tenosynovium for de Quervain’s disease. Orthopedics. 2002;25(1):68-70.
  23. Cavaleri R., Schabrun S.M., Te M., Chipchase L.S. Hand therapy versus corticosteroid injections in the treatment of de Quervain’s disease: A systematic review and meta-analysis. J. Hand Ther. 2016;29(1):3-11.
  24. Mardani-Kivi M., Karimi Mobarakeh M., Bahrami F. et al. Corticosteroid injection with or without thumb spica cast for de Quervain tenosynovitis. J. Hand Surg. Am. 2014;39(1):37-41.
  25. Mehdinasab S.A., Alemohammad S.A. Methylprednisolone acetate injection plus casting versus casting alone for the treatment of de Quervain’s tenosynovitis. Arch. Iran Med. 2010;13(4):270-4.
  26. Zingas C., Failla J.M., Van Holsbeeck M. Injection accuracy and clinical relief of de Quervain’s tendinitis. J. Hand Surg. Am. 1998;23(1):89-96.
  27. Mirzanli C., Ozturk K., Esenyel C.Z. et al. Accuracy of intrasheath injection techniques for de Quervain’s disease: a cadaveric study. J. Hand Surg. Eur. Vol. 2012;37(2):155-60.
  28. Tan M.Y., Low C.K., Tan S.K. De Quervain’s tenosynovitis and ganglion over first dorsal extensor retinacular compartment. Ann. Acad. Med. Singapore. 1994;23(6):885-6.
  29. Minamikawa Y., Peimer C.A., Cox W.L., Sherwin F.S. De Quervain’s syndrome: surgical and anatomical studies of the fibroosseous canal. Orthopedics. 1991;14(5):545-9.
  30. Gousheh J., Yavari M., Arasteh E. Division of the first dorsal compartment of the hand into two separate canals: rule or exception? Arch. Iran Med. 2009;12(1):52-4.
  31. Colio S.W., Smith J., Pourcho A.M. Ultrasound-Guided Interventional Procedures of the Wrist and Hand: Anatomy, Indications, and Techniques. Phys. Med. Rehabil. Clin. N. Am. 2016;27(3):589-605.
  32. Jeyapalan K., Choudhary S. Ultrasound-guided injection of triamcinolone and bupivacaine in the management of De Quervain’s disease. Skeletal Radiol. 2009;38(11):1099-1103.
  33. Hajder E., de Jonge M.C., van der Horst C.M., Obdeijn M.C. The role of ultrasound-guided triamcinolone injection in the treatment of de Quervain’s disease: treatment and a diagnostic tool? Chir. Main. 2013;32(6):403-7.
  34. Allam A.E., Al-Ashkar D.S., Negm A.A. et al. Ultrasound-guided methotrexate injection for De Quervain disease of the wrist: what lies beyond the horizon? J. Pain Res. 2017;26(10):2299-302.
  35. Gundes H., Tosun B. Longitudinal incision in surgical release of De Quervain disease. Tech. Hand Up Extrem. Surg. 2005;9(3):149-52.
  36. Abrisham S.J., Karbasi M.H., Zare J. et al. De qeurvian tenosynovitis: clinical outcomes of surgical treatment with longitudinal and transverse incision. Oman Med. J. 2011;26(2):91-3.
  37. Kumar K. Outcome of longitudinal versus transverse incision in de Quervain’s disease and its implications in Indian population. Musculoskelet. Surg. 2016;100(1):49-52.
  38. Mellor S.J., Ferris B.D. Complications of a simple procedure: de Quervain’s disease revisited. Int. J. Clin. Pract. 2000;54(2):76-7.
  39. Scheller A., Schuh R., Hönle W., Schuh A. Long-term results of surgical release of de Quervain’s stenosing tenosynovitis. Int. Orthop. 2009;33(5):1301-3.
  40. Altay M.A., Erturk C., Isikan U.E. De Quervain’s disease treatment using partial resection of the extensor retinaculum: A short-term results survey. Orthop. Traumatol. Surg. Res. 2011;97(5):489-93.
  41. Zarin M., Ahmad I. Surgical treatment of de Quervain’s disease. J. Coll. Physicians Surg. Pak. 2003;13(3):157-8.
  42. Ta K.T., Eidelman D., Thomson J.G. Patient satisfaction and outcomes of surgery for de Quervain’s tenosynovitis. J. Hand Surg. Am. 1999;24(5):1071-7.
  43. Watson J., Gonzalez M., Romero A., Kerns J. Neuromas of the hand and upper extremity. J. Hand Surg. Am. 2010;35(3):499-510.
  44. Vas L., Pai R. Complex Regional Pain Syndrome-Type 1 Presenting as de Quervain’s Stenosing Tenosynovitis. Pain Physician. 2016;19(1):227-34.
  45. McMahon M., Craig S.M., Posner M.A. Tendon subluxation after de Quervain’s release: treatment by brachioradialis tendon flap. J. Hand Surg. 1991;16(1):30-2.
  46. Kim J.H., Yang S.W., Ham H.J., Kim J.P. Tendon Subluxation After Surgical Release of the First Dorsal Compartment in De Quervain Disease. Ann. Plast. Surg. 2019;82(6):628-35.
  47. Kang H.J., Hahn S.B., Kim S.H., Choi Y.R. Does endoscopic release of the first extensor compartment have benefits over open release in de Quervain’s disease? J. Plast. Reconstr. Aesthet. Surg. 2011;64(10):1306-11.
  48. Kang H.J., Koh I.H., Jang J.W., Choi Y.R. Endoscopic versus open release in patients with de Quervain’s tenosynovitis: a randomised trial. Bone Joint J. 2013;95-B(7):947-51.
  49. Волков А.В., Малыгина М.А., Капранчук В.А. и др. Первый дорсальный костно-фиброзный канал предплечья, анатомические особенности, эндоскопическая лигаментотомия при болезни де Кервена. Кубанский научный медицинский вестник. 2014;1(143):54-60.
  50. Матев И., Банков С. Реабилитация при повреждениях руки. Пер. с болг. Н.В. Матвеевой. София: Медицина и физкультура; 1981.
  51. Duruöz M.T. Hand Function. A Practical Guide to Assessment. New York: Springer Science & Business Media; 2014.
  52. McCaffery M., Beebe A. Pain: Clinical Manual for Nursing Practice. Baltimore: V.V. Mosby Company; 1993.
  53. Horn K.K., Jennings S., Richardson G. et al. The Patient-Specific Functional Scale: psychometric, clinimetrics, and application as a clinical outcome measure. Graduate, School of Physiotherapy, University of Otago, New Zealand. 2010.
  54. Gummesson C., Ward M.M., Atroshi I. The shortened disabilities of the arm, shoulder and hand questionnaire (QuickDASH): validity and reliability based on responses within the full-length DASH. BMC Musculoskelet. Disord. 2006;77:44.
  55. Penta M., Thonnard J.L., Tesio L. ABILHAND: A Rash-Built Measure of Manual Ability. Arch. Phys. Med. Rehabil. 1998;79(9):1038-42.
  56. Watts A.M.I., Greenstock M., Cole R.P. Outcome following the rehabilitation of hand trauma patients. J. Hand Surg. 1998; 23B(4):485-9.
  57. Новиков А.В., Белова А.Н., Щедрина М.А., Донченко Е.В. Опросник для оценки повседневной жизненной активности больных с патологией кисти. Вестник травматологии и ортопедии им. Н.Н. Приорова. 2004;2:58-62.
  58. Macey A.C., Burke F.D. Outcome of hand surgery. J. Hand Surg. 1995;20B(6):841-52.



Abstract: 665

PDF (Russian): 1


Article Metrics

Metrics Loading ...



  • There are currently no refbacks.

Copyright (c) 2019 Eco-Vector

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies